Red flags of cardiac amyloidosis in patients with spinal stenosis and yellow ligament hypertrophy

Studies addressing the prevalence of cardiac amyloidosis (CA) among patients with spinal stenosis (SS) are lacking. The identification of the red flags (RF) of CA could lead to early detection of cases of CA. The primary objective of this study was to address the prevalence of RF of CA among patient...

Full description

Saved in:
Bibliographic Details
Published inMedicina clinica Vol. 162; no. 2; p. 60
Main Authors Negreira Caamaño, Martín, Ramírez Huaranga, Marco Aurelio, García Vicente, Ana María, Rienda Moreno, Miguel Ángel, Castro Corredor, David, Piqueras Flores, Jesús
Format Journal Article
LanguageEnglish
Published Spain 26.01.2024
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Studies addressing the prevalence of cardiac amyloidosis (CA) among patients with spinal stenosis (SS) are lacking. The identification of the red flags (RF) of CA could lead to early detection of cases of CA. The primary objective of this study was to address the prevalence of RF of CA among patients with SS. Transversal study including consecutive cases with SS and yellow ligament hypertrophy (YLH). A clinical assessment that included electrocardiogram, echocardiogram and urine and blood test was performed. A clinical suspicion of CA was defined by the presence of left ventricular hypertrophy plus any RF. One hundred and three patients with SS and YLH were assessed. The prevalence of RF was high: heart failure: 18.4%; aortic stenosis: 1.9%; carpal tunnel syndrome: 7.8%; bicipital tendon rupture: 1.9%; arterial hypotension: 17.4%; polyneuropathy symptoms: 51.5%; pseudoinfarction pattern: 3.9%; low voltages: 15.5%; conduction abnormalities: 15.5%; decreased longitudinal strain: 25.3%; apical sparing pattern: 3.9%. The 57.3% of the cohort met the CA suspicion criteria. The prevalence of RF of CA is high among patients with SS and YLH. A high proportion of patients met the CA suspicion criteria.
ISSN:1578-8989
DOI:10.1016/j.medcli.2023.09.016